A genetically encoded tool to increase cellular NADH/NAD+ ratio in living cells

Nat Chem Biol. 2024 May;20(5):594-604. doi: 10.1038/s41589-023-01460-w. Epub 2023 Oct 26.

Abstract

Impaired redox metabolism is a key contributor to the etiology of many diseases, including primary mitochondrial disorders, cancer, neurodegeneration and aging. However, mechanistic studies of redox imbalance remain challenging due to limited strategies that can perturb redox metabolism in various cellular or organismal backgrounds. Most studies involving impaired redox metabolism have focused on oxidative stress; consequently, less is known about the settings where there is an overabundance of NADH reducing equivalents, termed reductive stress. Here we introduce a soluble transhydrogenase from Escherichia coli (EcSTH) as a novel genetically encoded tool to promote reductive stress in living cells. When expressed in mammalian cells, EcSTH, and a mitochondrially targeted version (mitoEcSTH), robustly elevated the NADH/NAD+ ratio in a compartment-specific manner. Using this tool, we determined that metabolic and transcriptomic signatures of the NADH reductive stress are cellular background specific. Collectively, our novel genetically encoded tool represents an orthogonal strategy to promote reductive stress.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism
  • Escherichia coli* / genetics
  • Escherichia coli* / metabolism
  • HEK293 Cells
  • Humans
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • NAD* / metabolism
  • NADP Transhydrogenases / genetics
  • NADP Transhydrogenases / metabolism
  • Oxidation-Reduction*
  • Oxidative Stress

Substances

  • NAD
  • Escherichia coli Proteins
  • NADP Transhydrogenases